این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
Iranian Journal of Blood and Cancer، جلد ۱۰، شماره ۳، صفحات ۸۷-۹۱
عنوان فارسی -
چکیده فارسی مقاله
کلیدواژه‌های فارسی مقاله
عنوان انگلیسی Efficacy of Rituximab in the Treatment of Plasma Exchange Refractory Thrombotic Thrombocytopenic Purpura
چکیده انگلیسی مقاله Background: Rituximab can induce a durable remission in plasma exchange refractory thrombotic thrombocytopenic purpura (TTP). Timing of Rituximab infusion in combination with plasma exchange (PE) and long term follow-up for probable side effects of such treatment is still lacking. Methods: This study was conducted among 10 patients with plasma exchange refractory TTP. According to the study designation, first PE was performed within 36-48 hours after first dose of rituximab. Results: Eight of ten (80%) patients received 1 course of rituximab. Two of ten (20%) patients received another course of rituximab due to relapse. Repsonse rate (RR) to rituximab in combination with plasma exchange, was 90%. Overall Survival of the patients was 90% and 1 and 5-year relapse free survival rate (RFS) was 90% and 83%, respectively. One of the patients expired due to Systemic Lupus Erythematosus flare up. Conclusion: According to this study, treatment of refractory TTP with rituximab in combination with PE could be effective. Iranian Registry of Clinical Trials: IRCT2017012232125N1
کلیدواژه‌های انگلیسی مقاله
نویسندگان مقاله | Alireza Sadeghi
Assistant Professor, Department of Hematology-Oncology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.


| Farzaneh Ashrafi
Assistant Professor, Department of Hematology-Oncology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.


| Arman Sourani
Student Research Committee, School of medicine, Isfahan University of Medical sciences, Isfahan, Iran
نشانی اینترنتی http://ijbc.ir/browse.php?a_code=A-10-368-1&slc_lang=en&sid=1
فایل مقاله فایلی برای مقاله ذخیره نشده است
کد مقاله (doi)
زبان مقاله منتشر شده en
موضوعات مقاله منتشر شده Adults Hematology & Oncology
نوع مقاله منتشر شده پژوهشی
برگشت به: صفحه اول پایگاه   |   نسخه مرتبط   |   نشریه مرتبط   |   فهرست نشریات